Valuation: Abbott India Limited

Market Cap 593B 6.21B 5.45B 5.07B 4.67B 8.75B 8.9B 60.18B 23.56B 294B 23.3B 22.8B 1,016B P/E 2027 *
34.7x
P/E 2028 * 30.9x
Enterprise Value 569B 5.96B 5.23B 4.87B 4.48B 8.39B 8.54B 57.76B 22.61B 282B 22.37B 21.88B 975B EV / Sales 2027 *
7.58x
EV / Sales 2028 * 6.88x
Free-Float
24.45%
Yield 2027 *
2.07%
Yield 2028 * 2.23%
1 day+0.34%
1 week-1.30%
Current month+9.71%
1 month+9.05%
3 months+9.64%
6 months+0.80%
Current year-4.00%
1 week 27,500.7
Extreme 27500.7
29,250
1 month 25,195
Extreme 25195
29,250
Current year 25,164
Extreme 25164
29,250
1 year 25,164
Extreme 25164
35,280
3 years 21,907.45
Extreme 21907.45
35,921.55
5 years 15,525
Extreme 15525
35,921.55
10 years 3,996
Extreme 3996
35,921.55
Manager TitleAgeSince
Chief Executive Officer 46 2025-06-13
Director of Finance/CFO 52 2025-05-05
Director of Finance/CFO - 2025-03-31
Director TitleAgeSince
Chairman 83 1967-12-31
Director/Board Member 69 2011-02-28
Director/Board Member 71 2019-03-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%-1.30%-17.36%+18.19% 6.16B
+1.93%+3.85%+51.05%+166.24% 1,068B
+0.29%+6.43%+60.47%+52.87% 641B
+2.45%+2.77%+39.61%+74.48% 454B
+2.17%+10.91%+41.94%+35.03% 351B
+1.46%+5.93%+40.44%+43.69% 299B
+0.40%+4.52%+19.79%+20.93% 266B
+2.73%+2.26%-25.81%-36.98% 220B
+4.48%+7.33%+30.47%+66.31% 203B
+2.91%+3.10%+18.84%+74.76% 162B
Average +2.03%+2.32%+25.94%+51.55% 366.95B
Weighted average by Cap. +1.89%+2.84%+40.00%+80.04%

Financials

2027 *2028 *
Net sales 75.09B 786M 690M 642M 591M 1.11B 1.13B 7.62B 2.98B 37.24B 2.95B 2.89B 129B 82.25B 861M 756M 704M 647M 1.21B 1.23B 8.35B 3.27B 40.79B 3.23B 3.16B 141B
Net income 17.05B 179M 157M 146M 134M 252M 256M 1.73B 677M 8.46B 670M 656M 29.22B 19.12B 200M 176M 164M 150M 282M 287M 1.94B 759M 9.48B 751M 735M 32.76B
Net Debt -23.86B -250M -219M -204M -188M -352M -358M -2.42B -948M -11.83B -937M -917M -40.88B -26.92B -282M -247M -230M -212M -397M -404M -2.73B -1.07B -13.35B -1.06B -1.04B -46.13B
Logo Abbott India Limited
Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.
Employees
3,679
Date Price Change Volume
26-07-28 27,907.05 +0.34% 1,011
26-07-27 ₹27,813.40 -0.68% 444
26-07-24 ₹28,003.45 -2.55% 1,173
26-07-23 ₹28,735.45 -0.56% 909
26-07-22 ₹28,898.60 +0.43% 1,764
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBOTINDIA Stock